Inert Non Hodgkin's Lymphoma
1 clinical trials · Condition
◉ Watch Inert Non Hodgkin's Lymphoma
| Record | Firm | Date |
|---|---|---|
| IBI376 Plus Rituximab in Patients With Untreated Indolent Lymphoma. (NCT05073250) | Chinese PLA General Hospital | 2021-12-31 |
Track Inert Non Hodgkin's Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.